KC
Kaidala Chandrashekaraiah Janardhan
About Kaidala Chandrashekaraiah Janardhan
Kaidala Chandrashekaraiah Janardhan has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Spyblood Healthcare Private Limited and Whimper Pharmalabs Private Limited. Formerly with 1 company, such as Plotnew Bio Innovations Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Spyblood Healthcare Private Limited
U73200TG2021PTC157421
|
Director | 29 Nov 2021 | 2021 | Active |
Whimper Pharmalabs Private Limited
U21001KA2023PTC176584
|
Director | 27 Jul 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Plotnew Bio Innovations Private Limited
U74999KA2022PTC156248
|
Director | 04 Jan 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kaidala Chandrashekaraiah Janardhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kaidala Chandrashekaraiah Janardhan
Kaidala Chandrashekaraiah Janardhan has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Spyblood Healthcare Private Limited and Whimper Pharmalabs Private Limited. Formerly with 1 company, such as Plotnew Bio Innovations Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Kaidala Chandrashekaraiah Janardhan is associated with 2 companies as Director.
Kaidala Chandrashekaraiah Janardhan has expertise in Healthcare, General Business.
Kaidala Chandrashekaraiah Janardhan has 4 years in corporate governance.